Fujifilm Diosynth Biotechnologies is a leading global Contract Development and Manufacturing Organisation (CDMO) specialising in biologics and advanced therapies.

Fujifilm Diosynth Biotechnologies delivers integrated solutions for the development and manufacture of biologics, vaccines, and advanced therapies. With a commitment to innovation, the company operates state-of-the-art facilities across the United States, Europe, and Asia. Combining decades of experience with cutting-edge technology, Fujifilm Diosynth supports clients from early development through commercial production, focusing on speed, quality, and reliability to enable successful therapeutic outcomes.

Key Products and Services:

• Biologics: Mammalian and microbial drug substance manufacturing, process development, and cell line development.
• Advanced Therapies: Gene and cell therapy manufacturing and viral vector production.
• Vaccines: Development and production of drug substances and finished goods.
• Quality Services: Analytical and regulatory support, including cGMP compliance.

Final Paragraph:
Fujifilm Diosynth Biotechnologies partners with innovators worldwide, driving the development of life-changing treatments. By leveraging advanced technology and a client-focused approach, the company remains at the forefront of the biotechnology sector, committed to transforming patient care through exceptional CDMO services. For more information, visit Fujifilm Diosynth Biotechnologies.